EW
Edwards Lifesciences Corporation$84.90-0.84 (-0.98%)Prev Close$85.76·MCap$49.50B·P/E46.39·Vol2.97M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
39
$24.39M
◆
Net Activity
Net Seller
$24.39M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Edwards Lifesciences Corporation (EW) has been exclusively selling, with 0 insider purchases totaling $0.00 and 39 insider sales totaling $24.39M. The most recent insider transaction was by Dahl Andrew M. (officer: SVP, Corporate Controller), who sold $48.8K worth of shares on May 29, 2026. Edwards Lifesciences Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $49.50B.
EW Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Dahl Andrew M. | officer: SVP, Corporate Controller | Sell | 567 | $86.08 | $48.8K | 15,334 |
| May 27, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 23,145 | $86.42 | $2.00M | 98,611 |
| May 22, 2026 | Chopra Daveen | officer: CVP, TMTT & Surgical | Sell | 1,500 | $84.60 | $126.9K | 44,324 |
| May 18, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 620 | $81.14 | $50.3K | 40,411 |
| May 18, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 17,968 | $81.96 | $1.47M | 30,970-37% |
| May 12, 2026 | Zovighian Bernard J | director, officer: CEO | Sell | 36,351 | $77.93 | $2.83M | 47,546-43% |
| May 11, 2026 | Markowitz Wayne | officer: CVP, JAPAC | Sell | 593 | $79.73 | $47.3K | 21,680 |
| May 4, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 2,038 | $83.49 | $170.2K | 34,934 |
| Apr 9, 2026 | Ullem Scott B. | officer: CVP, Chief Financial Officer | Sell | 13,000 | $80.04 | $1.04M | 48,023 |
| Apr 6, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 1,019 | $80.98 | $82.5K | 33,934 |
| Mar 11, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 1,019 | $85.38 | $87.0K | 33,934 |
| Mar 11, 2026 | Ullem Scott B. | officer: CVP, Chief Financial Officer | Sell | 13,000 | $84.92 | $1.10M | 47,600 |
| Mar 2, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 11,340 | $85.93 | $974.4K | 21,266-35% |
| Feb 26, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 24,000 | $83.84 | $2.01M | 21,266-53% |
| Feb 22, 2026 | Dahl Andrew M. | SVP, Corporate Controller | Sell | 176 | $79.78 | $14.0K | 0 |
| Feb 22, 2026 | Lippis Daniel J. | CVP, TAVR | Sell | 432 | $79.78 | $34.5K | 0 |
| Feb 16, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 199 | $75.87 | $15.1K | 0 |
| Feb 13, 2026 | Zovighian Bernard J | director, officer: CEO | Sell | 22,430 | $76.67 | $1.72M | 103,794 |
| Feb 12, 2026 | Lippis Daniel J. | CVP, TAVR | Sell | 456 | $75.87 | $34.6K | 0 |
| Jan 9, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 2,038 | $85.70 | $174.7K | 22,002 |
| Jan 6, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 22,680 | $85.66 | $1.94M | 40,578-36% |
| Dec 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,386 | $83.76 | $953.7K | 0 |
| Dec 12, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 1,019 | $84.03 | $85.6K | 0 |
| Dec 12, 2025 | STONE HEISZ LESLIE | Director | Sell | 2,615 | $83.41 | $218.1K | 0 |
| Dec 11, 2025 | Chopra Daveen | CVP, TMTT & Surgical | Sell | 2,000 | $84.38 | $168.8K | 0 |
| Dec 10, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,340 | $83.83 | $950.6K | 0 |
| Dec 10, 2025 | Zovighian Bernard J | CEO | Sell | 25,350 | $84.95 | $2.15M | 0 |
| Dec 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 7,700 | $84.47 | $650.4K | 0 |
| Dec 8, 2025 | Markowitz Wayne | CVP, JAPAC | Sell | 583 | $86.01 | $50.1K | 0 |
| Nov 10, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 1,020 | $82.55 | $84.2K | 0 |
| Nov 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 13,000 | $83.08 | $1.08M | 0 |
| Sep 15, 2025 | Dahl Andrew M. | SVP, Corporate Controller | Sell | 262 | $77.57 | $20.3K | 0 |
| Sep 15, 2025 | Markowitz Wayne | CVP, JAPAC | Sell | 650 | $77.57 | $50.4K | 0 |
| Aug 25, 2025 | Chopra Daveen | CVP, TMTT | Sell | 2,500 | $81.95 | $204.9K | 0 |
| Aug 18, 2025 | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $78.06 | $698.7K | 0 |
| Jul 28, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 4,114 | $79.46 | $326.9K | 0 |
| Jul 11, 2025 | Bruls Annette | CVP, EMEACLA | Sell | 109 | $78.80 | $8.6K | 0 |
| Jul 7, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 333 | $76.79 | $25.6K | 0 |
| Jun 16, 2025 | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $75.23 | $673.3K | 0 |
| Jun 3, 2025 | Zovighian Bernard J | CEO | Sell | 17,066 | $77.22 | $1.32M | 0 |
| Jun 2, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 2,570 | $77.40 | $198.9K | 0 |
| May 22, 2025 | Chopra Daveen | CVP, TMTT | Sell | 1,500 | $75.07 | $112.6K | 0 |
| May 13, 2025 | Zovighian Bernard J | CEO | Sell | 2,860 | $73.68 | $210.7K | 0 |
| May 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 816 | $73.68 | $60.1K | 0 |
| May 12, 2025 | Chopra Daveen | CVP, TMTT | Sell | 580 | $73.68 | $42.7K | 0 |
| May 12, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 271 | $73.68 | $20.0K | 0 |
| May 12, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 1,200 | $73.68 | $88.4K | 0 |
| May 12, 2025 | Wood Larry L | Global President TAVR & Surg | Sell | 988 | $73.68 | $72.8K | 0 |
| May 9, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 851 | $74.92 | $63.8K | 0 |
| May 9, 2025 | Chopra Daveen | CVP, TMTT | Sell | 627 | $74.92 | $47.0K | 0 |
Showing 1–50 of 303
1 / 7
...
EW Insider Buying Activity
The following table shows recent insider purchases of Edwards Lifesciences Corporation (EW) stock reported via SEC Form 4 filings.
No insider buying activity found for EW in the last 12 months.
EW Insider Selling Activity
The following table shows recent insider sales of Edwards Lifesciences Corporation (EW) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Dahl Andrew M. | officer: SVP, Corporate Controller | Sell | 567 | $86.08 | $48.8K | 15,334 |
| May 27, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 23,145 | $86.42 | $2.00M | 98,611 |
| May 22, 2026 | Chopra Daveen | officer: CVP, TMTT & Surgical | Sell | 1,500 | $84.60 | $126.9K | 44,324 |
| May 18, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 620 | $81.14 | $50.3K | 40,411 |
| May 18, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 17,968 | $81.96 | $1.47M | 30,970-37% |
| May 12, 2026 | Zovighian Bernard J | director, officer: CEO | Sell | 36,351 | $77.93 | $2.83M | 47,546-43% |
| May 11, 2026 | Markowitz Wayne | officer: CVP, JAPAC | Sell | 593 | $79.73 | $47.3K | 21,680 |
| May 4, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 2,038 | $83.49 | $170.2K | 34,934 |
| Apr 9, 2026 | Ullem Scott B. | officer: CVP, Chief Financial Officer | Sell | 13,000 | $80.04 | $1.04M | 48,023 |
| Apr 6, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 1,019 | $80.98 | $82.5K | 33,934 |
| Mar 11, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 1,019 | $85.38 | $87.0K | 33,934 |
| Mar 11, 2026 | Ullem Scott B. | officer: CVP, Chief Financial Officer | Sell | 13,000 | $84.92 | $1.10M | 47,600 |
| Mar 2, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 11,340 | $85.93 | $974.4K | 21,266-35% |
| Feb 26, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 24,000 | $83.84 | $2.01M | 21,266-53% |
| Feb 22, 2026 | Dahl Andrew M. | SVP, Corporate Controller | Sell | 176 | $79.78 | $14.0K | 0 |
| Feb 22, 2026 | Lippis Daniel J. | CVP, TAVR | Sell | 432 | $79.78 | $34.5K | 0 |
| Feb 16, 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 199 | $75.87 | $15.1K | 0 |
| Feb 13, 2026 | Zovighian Bernard J | director, officer: CEO | Sell | 22,430 | $76.67 | $1.72M | 103,794 |
| Feb 12, 2026 | Lippis Daniel J. | CVP, TAVR | Sell | 456 | $75.87 | $34.6K | 0 |
| Jan 9, 2026 | Lippis Daniel J. | officer: CVP, TAVR | Sell | 2,038 | $85.70 | $174.7K | 22,002 |
| Jan 6, 2026 | BOBO DONALD E JR | officer: CVP,Strategy/Corp Development | Sell | 22,680 | $85.66 | $1.94M | 40,578-36% |
| Dec 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,386 | $83.76 | $953.7K | 0 |
| Dec 12, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 1,019 | $84.03 | $85.6K | 0 |
| Dec 12, 2025 | STONE HEISZ LESLIE | Director | Sell | 2,615 | $83.41 | $218.1K | 0 |
| Dec 11, 2025 | Chopra Daveen | CVP, TMTT & Surgical | Sell | 2,000 | $84.38 | $168.8K | 0 |
| Dec 10, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 11,340 | $83.83 | $950.6K | 0 |
| Dec 10, 2025 | Zovighian Bernard J | CEO | Sell | 25,350 | $84.95 | $2.15M | 0 |
| Dec 9, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 7,700 | $84.47 | $650.4K | 0 |
| Dec 8, 2025 | Markowitz Wayne | CVP, JAPAC | Sell | 583 | $86.01 | $50.1K | 0 |
| Nov 10, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 1,020 | $82.55 | $84.2K | 0 |
| Nov 10, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 13,000 | $83.08 | $1.08M | 0 |
| Sep 15, 2025 | Dahl Andrew M. | SVP, Corporate Controller | Sell | 262 | $77.57 | $20.3K | 0 |
| Sep 15, 2025 | Markowitz Wayne | CVP, JAPAC | Sell | 650 | $77.57 | $50.4K | 0 |
| Aug 25, 2025 | Chopra Daveen | CVP, TMTT | Sell | 2,500 | $81.95 | $204.9K | 0 |
| Aug 18, 2025 | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $78.06 | $698.7K | 0 |
| Jul 28, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 4,114 | $79.46 | $326.9K | 0 |
| Jul 11, 2025 | Bruls Annette | CVP, EMEACLA | Sell | 109 | $78.80 | $8.6K | 0 |
| Jul 7, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 333 | $76.79 | $25.6K | 0 |
| Jun 16, 2025 | Wood Larry L | Global President TAVR & Surg | Sell | 8,950 | $75.23 | $673.3K | 0 |
| Jun 3, 2025 | Zovighian Bernard J | CEO | Sell | 17,066 | $77.22 | $1.32M | 0 |
| Jun 2, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 2,570 | $77.40 | $198.9K | 0 |
| May 22, 2025 | Chopra Daveen | CVP, TMTT | Sell | 1,500 | $75.07 | $112.6K | 0 |
| May 13, 2025 | Zovighian Bernard J | CEO | Sell | 2,860 | $73.68 | $210.7K | 0 |
| May 12, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 816 | $73.68 | $60.1K | 0 |
| May 12, 2025 | Chopra Daveen | CVP, TMTT | Sell | 580 | $73.68 | $42.7K | 0 |
| May 12, 2025 | Lippis Daniel J. | CVP, JAPAC | Sell | 271 | $73.68 | $20.0K | 0 |
| May 12, 2025 | Ullem Scott B. | CVP, Chief Financial Officer | Sell | 1,200 | $73.68 | $88.4K | 0 |
| May 12, 2025 | Wood Larry L | Global President TAVR & Surg | Sell | 988 | $73.68 | $72.8K | 0 |
| May 9, 2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 851 | $74.92 | $63.8K | 0 |
| May 9, 2025 | Chopra Daveen | CVP, TMTT | Sell | 627 | $74.92 | $47.0K | 0 |
EW Insiders
Similar Stocks to EW
ISRG
Intuitive Surgical, Inc.
$410.38-0.59%
$149.48B
SYK
Stryker Corporation
$311.49+1.97%
$117.18B
BSX
Boston Scientific Corporation
$46.98-0.38%
$72.16B
DXCM
DexCom, Inc.
$75.26+0.07%
$29.57B
RMD
ResMed Inc.
$193.86+0.75%
$28.44B
ZBH
Zimmer Biomet Holdings, Inc.
$88.54+1.61%
$16.88B
PEN
Penumbra, Inc.
$318.44+0.04%
$12.59B
PODD
Insulet Corporation
$149.64+0.31%
$11.06B